Clinical trial
Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the…
NCT00087555 · Jazz Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00087555 |
|---|---|
| Title | Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia |
| Official title | Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial Comparing the Effects of Orally Administered Xyrem(R) (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia |
| Lead sponsor | Jazz Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fibromyalgia |
| Intervention type | Drug |
| Interventions | Xyrem (sodium oxybate) oral solution, Placebo |
| Enrollment | 195 |
| Start date | Jul 1, 2004 |
| Primary completion | Apr 1, 2005 |
| Completion | Jan 1, 2006 |
| First posted | Jul 14, 2004 |
| Last update posted | Jan 24, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: